Published in Reprod Biol Endocrinol on September 22, 2009
Recombinant human follicle-stimulating hormone produces more oocytes with a lower total dose per cycle in assisted reproductive technologies compared with highly purified human menopausal gonadotrophin: a meta-analysis. Reprod Biol Endocrinol (2010) 0.92
What is the best treatment option for infertile women aged 40 and over? J Assist Reprod Genet (2013) 0.86
'Inconvenient biology:' advantages and disadvantages of first-time parenting after age 40 using in vitro fertilization. Hum Reprod (2012) 0.83
Female aging alters expression of human cumulus cells genes that are essential for oocyte quality. Biomed Res Int (2014) 0.81
Addition of low dose hCG to rFSh benefits older women during ovarian stimulation for IVF. Reprod Biol Endocrinol (2012) 0.79
Amino acid turnover by human oocytes is influenced by gamete developmental competence, patient characteristics and gonadotrophin treatment. Hum Reprod (2013) 0.78
Myo-inositol therapy for poor-responders during IVF: a prospective controlled observational trial. J Ovarian Res (2015) 0.78
Relation of cumulus cell status with single oocyte maturity, fertilization capability and patient age. J Reprod Infertil (2014) 0.78
Fertility preservation options after gonadotoxic chemotherapy. Clin Med Insights Reprod Health (2013) 0.78
Chronological age vs biological age: an age-related normogram for antral follicle count, FSH and anti-Mullerian hormone. J Assist Reprod Genet (2013) 0.76
Sleep in women undergoing in vitro fertilization: a pilot study. Sleep Med (2016) 0.75
Ameliorating effect of Erxian decoction combined with Fructus Schisandrae chinensis (Wu Wei Zi) on menopausal sweating and serum hormone profiles in a rat model. Chin Med (2016) 0.75
Age-related expression of TGF beta family receptors in human cumulus oophorus cells. J Assist Reprod Genet (2017) 0.75
Executive summary: Stages of Reproductive Aging Workshop (STRAW). Fertil Steril (2001) 5.36
Birth after the reimplantation of a human embryo. Lancet (1978) 4.69
A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update (2006) 4.24
Factors that affect outcome of in-vitro fertilisation treatment. Lancet (1996) 4.13
Oocyte-specific deletion of Pten causes premature activation of the primordial follicle pool. Science (2008) 3.80
Initial and cyclic recruitment of ovarian follicles. Endocr Rev (2000) 3.76
Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause. Hum Reprod (1992) 3.66
Serum anti-Müllerian hormone levels: a novel measure of ovarian reserve. Hum Reprod (2002) 3.59
The variability of female reproductive ageing. Hum Reprod Update (2002) 3.52
Embryo morphology, developmental rates, and maternal age are correlated with chromosome abnormalities. Fertil Steril (1995) 3.49
Antimüllerian hormone serum levels: a putative marker for ovarian aging. Fertil Steril (2002) 3.03
Poor oocyte quality rather than implantation failure as a cause of age-related decline in female fertility. Lancet (1991) 2.80
Regulation of ovarian function: the role of anti-Müllerian hormone. Reproduction (2002) 2.80
Aromatic hydrocarbon receptor-driven Bax gene expression is required for premature ovarian failure caused by biohazardous environmental chemicals. Nat Genet (2001) 2.79
Fertility and ageing. Hum Reprod Update (2005) 2.68
Age and infertility. Science (1986) 2.33
Serum anti-Müllerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3. Hum Reprod (2003) 2.30
Age and basal follicle stimulating hormone as predictors of in vitro fertilisation outcome. Br J Obstet Gynaecol (1998) 2.29
Early follicular antimüllerian hormone as an indicator of ovarian reserve. Fertil Steril (2006) 2.29
Anti-mullerian hormone and inhibin B in the definition of ovarian aging and the menopause transition. J Clin Endocrinol Metab (2008) 2.27
Follicle-stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome. Fertil Steril (1989) 2.27
The effects of radiotherapy and chemotherapy on female reproduction. Hum Reprod Update (2001) 2.25
Serum anti-Müllerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles--implications for individualization of therapy. Hum Reprod (2007) 2.12
A model conforming the decline in follicle numbers to the age of menopause in women. Hum Reprod (1996) 1.88
Preimplantation genetic diagnosis reduces pregnancy loss in women aged 35 years and older with a history of recurrent miscarriages. Fertil Steril (2005) 1.83
Characterization of reproductive hormonal dynamics in the perimenopause. J Clin Endocrinol Metab (1996) 1.80
Exogenous luteinizing hormone in controlled ovarian hyperstimulation for assisted reproduction techniques. Fertil Steril (2004) 1.78
Anti-Müllerian hormone-based approach to controlled ovarian stimulation for assisted conception. Hum Reprod (2009) 1.74
Age at natural menopause in a population-based screening cohort: the role of menarche, fecundity, and lifestyle factors. Fertil Steril (1997) 1.67
Prolongation of ovarian lifespan into advanced chronological age by Bax-deficiency. Nat Genet (1999) 1.64
Menstrual cyclicity and the pre-menopause. Maturitas (1981) 1.63
Follicular oestrogen synthesis: the 'two-cell, two-gonadotrophin' model revisited. Mol Cell Endocrinol (1994) 1.63
Ovarian response to follicle-stimulating hormone (FSH) stimulation depends on the FSH receptor genotype. J Clin Endocrinol Metab (2000) 1.60
Cigarette smoking and reproductive function. Curr Opin Obstet Gynecol (2008) 1.56
Can assisted reproduction technology compensate for the natural decline in fertility with age? A model assessment. Hum Reprod (2004) 1.54
Ovarian tissue cryopreservation and transplantation: a review. Hum Reprod Update (2006) 1.54
Cytotoxic-induced ovarian failure in women with Hodgkin's disease. I. Hormone function. JAMA (1979) 1.52
How to improve the probability of pregnancy in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis. Fertil Steril (2008) 1.48
Follicular phase hormone levels and menstrual bleeding status in the approach to menopause. Fertil Steril (2005) 1.47
Age-related changes of the population of human ovarian follicles: increase in the disappearance rate of non-growing and early-growing follicles in aging women. Biol Reprod (1994) 1.47
Monitoring reproductive aging in a 5-year prospective study: aggregate and individual changes in luteinizing hormone and follicle-stimulating hormone with age. Menopause (2007) 1.46
Current concepts of the roles of follicle stimulating hormone and luteinizing hormone in folliculogenesis. Hum Reprod (1994) 1.44
Absence of effect of adjuvant growth hormone therapy on follicular responses to exogenous gonadotropins in women: normal and poor responders. Fertil Steril (1992) 1.42
Presence and absence of follicle-stimulating hormone receptor mutations provide some insights into spontaneous ovarian hyperstimulation syndrome physiopathology. J Clin Endocrinol Metab (2005) 1.33
Among patients treated with FSH and GnRH analogues for in vitro fertilization, is the addition of recombinant LH associated with the probability of live birth? A systematic review and meta-analysis. Hum Reprod Update (2007) 1.28
Recombinant Luteinizing Hormone (rLH) for controlled ovarian hyperstimulation in assisted reproductive cycles. Cochrane Database Syst Rev (2007) 1.28
Age-dependent decrease in embryo implantation rate after in vitro fertilization. Fertil Steril (1996) 1.27
Endometriosis and infertility. Fertil Steril (2006) 1.27
Low oocyte mitochondrial DNA content in ovarian insufficiency. Hum Reprod (2004) 1.25
Mechanisms of premature ovarian failure. Ann Endocrinol (Paris) (2003) 1.20
Investigation of the infertile couple: investigation of the infertile couple in the era of assisted reproductive technology: a time for reappraisal. Hum Reprod (2000) 1.19
An elevated basal FSH reflects a quantitative rather than qualitative decline of the ovarian reserve. Hum Reprod (2004) 1.17
Laparoscopic surgery for subfertility associated with endometriosis. Cochrane Database Syst Rev (2002) 1.16
Oocyte control of granulosa cell development: how and why. Hum Reprod (1997) 1.14
Early ovarian ageing: a hypothesis. Detection and clinical relevance. Hum Reprod (2003) 1.14
Effects of recombinant LH supplementation in women undergoing assisted reproduction with GnRH agonist down-regulation and stimulation with recombinant FSH: an opening study. Reprod Biomed Online (2004) 1.12
Relationship between fertilization results after intracytoplasmic sperm injection, and intrafollicular steroid, pituitary hormone and cytokine concentrations. Hum Reprod (1999) 1.12
Management of endometriomas in women requiring IVF: to touch or not to touch. Hum Reprod (2008) 1.10
Developmental and endocrine aspects of normal ovarian aging. Mol Cell Endocrinol (1998) 1.10
A common single nucleotide polymorphism in exon 10 of the human follicle stimulating hormone receptor is a major determinant of length and hormonal dynamics of the menstrual cycle. J Clin Endocrinol Metab (2005) 1.09
FSH induction of functional LH receptors in granulosa cells cultured in a chemically defined medium. Nature (1979) 1.08
Randomized trial to compare the effect of recombinant human FSH (follitropin alfa) with or without recombinant human LH in women undergoing assisted reproduction treatment. Reprod Biomed Online (2004) 1.08
Morphological study of the ovaries of leukaemic children. Br J Cancer (1978) 1.07
Adjuvant growth hormone therapy in poor responders to in-vitro fertilization: a prospective randomized placebo-controlled double-blind study. Hum Reprod (1995) 1.07
Ovarian response and pregnancy outcome in poor-responder women: a randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles. Fertil Steril (2007) 1.06
Impact of repeated antral follicle counts on the prediction of poor ovarian response in women undergoing in vitro fertilization. Fertil Steril (2004) 1.06
Ultrastructure of human ovarian primordial follicles after combination chemotherapy for Hodgkin's disease. Hum Reprod (1993) 1.05
Active smoking compromises IVF outcome and affects ovarian reserve. Reprod Biomed Online (2008) 1.04
Age, pregnancy and miscarriage: uterine versus ovarian factors. Hum Reprod (1993) 1.04
Biological versus chronological ageing of oocytes, distinguishable by raised FSH levels in relation to the success of IVF treatment. Hum Reprod (2002) 1.04
Regulation of gonadotropins by inhibin and activin. Semin Reprod Med (2004) 1.02
Lower apoptosis rate in human cumulus cells after administration of recombinant luteinizing hormone to women undergoing ovarian stimulation for in vitro fertilization procedures. Fertil Steril (2006) 1.01
Occurrence and biological properties of a common genetic variant of luteinizing hormone. J Clin Endocrinol Metab (1995) 1.00
The antral follicle count is a better marker than basal follicle-stimulating hormone for the selection of older patients with acceptable pregnancy prospects after in vitro fertilization. Fertil Steril (2005) 0.99
Reproductive aging and variability in the ovarian antral follicle count: application in the clinical setting. Fertil Steril (2003) 0.99
Should endometriomas be treated before IVF-ICSI cycles? Hum Reprod Update (2005) 0.98
Suboptimal response to GnRHa long protocol is associated with a common LH polymorphism. Reprod Biomed Online (2009) 0.97
Increased risk of early menopausal transition and natural menopause after poor response at first IVF treatment. Hum Reprod (2003) 0.97
Observations on 767 clinical pregnancies and 500 births after human in-vitro fertilization. Hum Reprod (1986) 0.97
Expected poor responders on the basis of an antral follicle count do not benefit from a higher starting dose of gonadotrophins in IVF treatment: a randomized controlled trial. Hum Reprod (2004) 0.96
Is there a link between an extremely poor response to ovarian hyperstimulation and early ovarian failure? Hum Reprod (2002) 0.95
Gonadotropin-releasing hormone (GnRH) antagonist plus recombinant luteinizing hormone vs. a standard GnRH agonist short protocol in patients at risk for poor ovarian response. Fertil Steril (2006) 0.94
The role of gonadotropins in the selection of the preovulatory follicle. Clin Obstet Gynecol (1984) 0.94
Poor response to ovulation induction is a stronger predictor of early menopause than elevated basal FSH: a life table analysis. Hum Reprod (2003) 0.94
Improvement of delivery and live birth rates after ICSI in women aged >40 years by ovarian co-stimulation with growth hormone. Hum Reprod (2005) 0.94
Evaluation of two doses of recombinant luteinizing hormone supplementation in an unselected group of women undergoing follicular stimulation for in vitro fertilization. Fertil Steril (2005) 0.93
A low number of retrieved oocytes at in vitro fertilization treatment is predictive of early menopause. Fertil Steril (2002) 0.92
Chaotic mosaicism in human preimplantation embryos is correlated with a low mitochondrial membrane potential. Fertil Steril (2003) 0.92
The paradox of declining fertility but increasing twinning rates with advancing maternal age. Hum Reprod (2006) 0.92
Non-response to ovarian stimulation in normogonadotrophic, normogonadal women: a clinical sign of impending onset of ovarian failure pre-empting the rise in basal follicle stimulating hormone levels. Hum Reprod (1997) 0.92
Rescue of IVF cycles by HMG in pituitary down-regulated normogonadotrophic young women characterized by a poor initial response to recombinant FSH. Hum Reprod (2001) 0.91
Structural and ultrastructural study of the ovary in childhood leukemia after successful treatment. Cancer (1990) 0.91
Increased prevalence of luteinizing hormone beta-subunit variant in Japanese infertility patients. Hum Reprod (1998) 0.91
Insulin-like growth factor I as an intraovarian regulator: basic and clinical implications. Ann N Y Acad Sci (1991) 0.91
Human oocytes and preimplantation embryos express mRNA for growth hormone receptor. Zygote (2003) 0.90
A double-blind cross-over controlled study to evaluate the effect of human biosynthetic growth hormone on ovarian stimulation in previous poor responders to in-vitro fertilization. Hum Reprod (1994) 0.90
Anatomy of the human ovarian insulin-like growth factor system. Biol Reprod (1993) 0.90
Cotreatment with growth hormone, after pituitary suppression, for ovarian stimulation in in vitro fertilization: a randomized, double-blind, placebo-control trial. Fertil Steril (1991) 0.90
Effects of recombinant LH (rLH) supplementation during controlled ovarian hyperstimulation (COH) in normogonadotrophic women with an initial inadequate response to recombinant FSH (rFSH) after pituitary downregulation. Clin Endocrinol (Oxf) (2004) 0.89
Consistent high clinical pregnancy rates and low ovarian hyperstimulation syndrome rates in high-risk patients after GnRH agonist triggering and modified luteal support: a retrospective multicentre study. Hum Reprod (2013) 2.23
Sperm chromatin structure assay parameters measured after density gradient centrifugation are not predictive for the outcome of ART. Hum Reprod (2007) 1.60
The effect of transdermal testosterone gel pretreatment on controlled ovarian stimulation and IVF outcome in low responders. Fertil Steril (2011) 1.57
Premenopausal mammographic density in relation to cyclic variations in endogenous sex hormone levels, prolactin, and insulin-like growth factors. Cancer Res (2009) 1.35
GnRHa trigger and modified luteal support with one bolus of hCG should be used with caution in extreme responder patients. Hum Reprod (2013) 1.18
Improving the patient's experience of IVF/ICSI: a proposal for an ovarian stimulation protocol with GnRH antagonist co-treatment. Hum Reprod (2009) 1.08
Glucocorticoid regulation of SLIT/ROBO tumour suppressor genes in the ovarian surface epithelium and ovarian cancer cells. PLoS One (2011) 1.08
GnRH agonist triggering: recent developments. Reprod Biomed Online (2012) 1.08
The antral follicle count: practical recommendations for better standardization. Fertil Steril (2009) 1.07
CYP3A variation, premenopausal estrone levels, and breast cancer risk. J Natl Cancer Inst (2012) 1.06
Triggering of final oocyte maturation with gonadotropin-releasing hormone agonist or human chorionic gonadotropin. Live birth after frozen-thawed embryo replacement cycles. Fertil Steril (2007) 1.04
LH-receptor gene expression in human granulosa and cumulus cells from antral and preovulatory follicles. J Clin Endocrinol Metab (2012) 0.99
Preovulatory progesterone concentration associates significantly to follicle number and LH concentration but not to pregnancy rate. Reprod Biomed Online (2011) 0.97
The impact of male overweight on semen quality and outcome of assisted reproduction. Asian J Androl (2014) 0.97
Corifollitropin alfa followed by rFSH in a GnRH antagonist protocol for poor ovarian responder patients: an observational pilot study. Fertil Steril (2012) 0.97
A combined analysis of data to identify predictive factors for spermatogenesis in men with hypogonadotropic hypogonadism treated with recombinant human follicle-stimulating hormone and human chorionic gonadotropin. Fertil Steril (2008) 0.96
Dose of recombinant FSH and oestradiol concentration on day of HCG affect embryo development kinetics. Reprod Biomed Online (2012) 0.94
Empty follicle syndrome after GnRHa triggering versus hCG triggering in COS. J Assist Reprod Genet (2012) 0.94
New algorithm for OHSS prevention. Reprod Biol Endocrinol (2011) 0.93
Conventional ovarian stimulation no longer exists: welcome to the age of individualized ovarian stimulation. Reprod Biomed Online (2011) 0.92
Hormonal, functional and genetic biomarkers in controlled ovarian stimulation: tools for matching patients and protocols. Reprod Biol Endocrinol (2012) 0.92
The type of GnRH analogue used during controlled ovarian stimulation influences early embryo developmental kinetics: a time-lapse study. Eur J Obstet Gynecol Reprod Biol (2013) 0.92
Connective tissue growth factor in the ovarian paracrine system. Mol Cell Endocrinol (2002) 0.92
FSH and TGF-beta superfamily members regulate granulosa cell connective tissue growth factor gene expression in vitro and in vivo. Endocrinology (2002) 0.91
Prenatal programming of metabolic syndrome in the common marmoset is associated with increased expression of 11beta-hydroxysteroid dehydrogenase type 1. Diabetes (2009) 0.90
Psychological aspects of male fertility treatment. J Adv Nurs (2012) 0.89
GnRH agonist ovulation trigger and hCG-based, progesterone-free luteal support: a proof of concept study. Hum Reprod (2011) 0.89
Antiinflammatory steroid action in human ovarian surface epithelial cells. J Clin Endocrinol Metab (2004) 0.88
Follicular growth and oocyte competence in the in vitro cultured mouse follicle: effects of gonadotrophins and steroids. Mol Hum Reprod (2008) 0.88
A prospective study, using sibling oocytes, examining the effect of 30 seconds versus 90 minutes gamete co-incubation in IVF. Hum Reprod (2005) 0.88
Connective tissue growth factor expression in the human corpus luteum: paracrine regulation by human chorionic gonadotropin. J Clin Endocrinol Metab (2005) 0.87
Oestrogen formation and connective tissue growth factor expression in rat granulosa cells. J Endocrinol (2007) 0.87
Pregnancy loss after frozen-embryo transfer--a comparison of three protocols. Fertil Steril (2012) 0.86
LH (as HCG) and FSH surges for final oocyte maturation: sometimes it takes two to tango? Reprod Biomed Online (2010) 0.85
Cortisol inactivation by 11beta-hydroxysteroid dehydrogenase-2 may enhance endometrial angiogenesis via reduced thrombospondin-1 in heavy menstruation. J Clin Endocrinol Metab (2009) 0.85
The role of preimplantation genetic diagnosis in diagnosing embryo aneuploidy. Curr Opin Obstet Gynecol (2009) 0.85
Identification of the high-risk patient for ovarian hyperstimulation syndrome. Semin Reprod Med (2010) 0.84
Regulation of 3beta-hydroxysteroid dehydrogenase type 1 and type 2 gene expression and function in the human ovarian surface epithelium by cytokines. Mol Hum Reprod (2009) 0.84
Local levonorgestrel regulation of androgen receptor and 17beta-hydroxysteroid dehydrogenase type 2 expression in human endometrium. Hum Reprod (2003) 0.83
Higher birth rate after recombinant hCG triggering compared with urinary-derived hCG in single-blastocyst IVF antagonist cycles: a randomized controlled trial. Fertil Steril (2010) 0.83
A common polymorphic allele of the LH beta-subunit gene is associated with higher exogenous FSH consumption during controlled ovarian stimulation for assisted reproductive technology. Reprod Biol Endocrinol (2013) 0.83
Ovarian hyperstimulation syndrome in the 21st century: the role of gonadotropin-releasing hormone agonist trigger and kisspeptin. Curr Opin Obstet Gynecol (2015) 0.83
Role of luteal glucocorticoid metabolism during maternal recognition of pregnancy in women. Endocrinology (2007) 0.83
Aromatase inhibitors in stimulated IVF cycles. Reprod Biol Endocrinol (2011) 0.83
Lysyl oxidase gene expression and enzyme activity in the rat ovary: regulation by follicle-stimulating hormone, androgen, and transforming growth factor-beta superfamily members in vitro. Endocrinology (2003) 0.82
Steroid signalling in the ovarian surface epithelium. Trends Endocrinol Metab (2005) 0.82
A review of luteinising hormone and human chorionic gonadotropin when used in assisted reproductive technology. Reprod Biol Endocrinol (2014) 0.81
Anti-Müllerian hormone versus antral follicle count for defining the starting dose of FSH. Reprod Biomed Online (2013) 0.81
Glucocorticoid receptor-mediated regulation of MMP9 gene expression in human ovarian surface epithelial cells. Fertil Steril (2008) 0.81
Comparison of gene expression profiles in granulosa and cumulus cells after ovulation induction with either human chorionic gonadotropin or a gonadotropin-releasing hormone agonist trigger. Fertil Steril (2013) 0.81
Research challenge: what is the best non-invasive test of oocyte/embryo competence? Mol Hum Reprod (2008) 0.81
Impact of GnRH agonist triggering and intensive luteal steroid support on live-birth rates and ovarian hyperstimulation syndrome: a retrospective cohort study. J Ovarian Res (2013) 0.80
The circadian variation in Anti-Müllerian hormone in patients with polycystic ovary syndrome differs significantly from normally ovulating women. PLoS One (2013) 0.80
Thrombospondin-1 inhibits angiogenesis and promotes follicular atresia in a novel in vitro angiogenesis assay. Endocrinology (2010) 0.79
3beta-Hydroxysteroid dehydrogenases and pre-receptor steroid metabolism in the human ovarian surface epithelium. Mol Cell Endocrinol (2008) 0.79
Use of acupuncture in female infertility and a summary of recent acupuncture studies related to embryo transfer. Acupunct Med (2006) 0.79
Polymorphisms in the protein C inhibitor gene in in vitro fertilization failure. Fertil Steril (2009) 0.78
IL1α and IL4 signalling in human ovarian surface epithelial cells. J Endocrinol (2011) 0.78
Are endogenous LH levels during ovarian stimulation for IVF using GnRH analogues associated with the probability of ongoing pregnancy? A systematic review. Hum Reprod Update (2006) 0.78
Regulation of 11beta-hydroxysteroid dehydrogenase type 1 gene expression in human ovarian surface epithelial cells by interleukin-1. Hum Reprod (2002) 0.77
Increasing vaginal progesterone gel supplementation after frozen-thawed embryo transfer significantly increases the delivery rate. Reprod Biomed Online (2012) 0.77
Polar bodies: their biological mystery and clinical meaning. Mol Hum Reprod (2011) 0.76
The gonadotropin-releasing hormone antagonist protocol--the protocol of choice for the polycystic ovary syndrome patient undergoing controlled ovarian stimulation. Acta Obstet Gynecol Scand (2012) 0.76
Azoospermia and ring chromosome 9--a case report. J Assist Reprod Genet (2014) 0.75
Midluteal serum progesterone levels and pregnancy following ovulation induction with human follicle-stimulating hormone: results of a combined-data analysis. J Reprod Med (2011) 0.75
[Fertility treatment in Denmark--development and challenges]. Ugeskr Laeger (2012) 0.75
Modern methods of fertility preservation: a tribute to Roger Gosden. Mol Hum Reprod (2012) 0.75
100 years of hormones: pathway biology as the fifth force in endocrinology. J Endocrinol (2005) 0.75
Motivational interviewing: a part of the weight loss program for overweight and obese women prior to fertility treatment. Gynecol Endocrinol (2013) 0.75
The ovary: from basic research to clinic. Mol Hum Reprod (2009) 0.75
Prenatal diagnostics in TESA/PESA pregnancies in Denmark 1995-2007: a shift from invasive procedures to nuchal translucency examination. Syst Biol Reprod Med (2011) 0.75
New research horizons. Mol Hum Reprod (2007) 0.75
Folliculogenesis and oogenesis: from basic science to the clinic. Mol Hum Reprod (2010) 0.75
Molecular diagnosis in the ART laboratory: making it matter. Mol Hum Reprod (2010) 0.75
Klinefelter's syndrome: from chromosome to clinic. Mol Hum Reprod (2010) 0.75
Stem cell roles in reproduction: what is the basic science? Mol Hum Reprod (2010) 0.75